DanielJeremyKassMD
Pulmonology • Pittsburgh, PACritical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Assistant Professor, Medicine, University of Pittsburgh School of Medicine
Dr. Kass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 Fifth Avenue
Pittsburgh, PA 15213Phone+1 412-432-5500- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
New York University School of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2009 - 2024
NY State Medical License 2000 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2003 Jan 01
- Dorothy P. and Richard P. Simmons Center for ILD Research Registry Start of enrollment: 2003 Oct 01
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2005 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;BMC Pulmonary Medicine. 2024 Mar 20
- Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;Research Square. 2024 Feb 28
- 1 citationsIncreased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis.Bahudhanapati, H., Tan, J., Apel, R., Seeliger, B., Schupp, J., Li, X., Sullivan, D., Sembrat, J., Rojas, M., Tabib, T., Valenzi, E., Lafyatis, R., Mitash, N., Hernand...> ;The European Respiratory Journal. 2024 Jan 1
- Join now to see all
Press Mentions
- National Initiatives to Prevent Myocardial Infarction and StrokeMarch 12th, 2021
He Saw ‘No Proof’ Closures Would Curb Virus. Now He Has De Blasio’s TrustMay 14th, 2020
Grant Support
- Methionine Aminopeptidase 2 In Pulmonary FibrosisNational Heart, Lung, And Blood Institute2010–2012
- Methionine Aminopeptidase 2 In Pulmonary FibrosisNational Heart, Lung, And Blood Institute2008–2010
Hospital Affiliations
UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
UPMC St. MargaretPittsburgh, Pennsylvania
UPMC HorizonFarrell, Pennsylvania
UPMC Children's Hospital of PittsburghPittsburgh, Pennsylvania
UPMC JamesonNew Castle, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
